DiviDrip · AKBA

AKBA — Akebia Therapeutics, Inc.

AKBA is Akebia Therapeutics, Inc. (Healthcare) — a non-dividend-paying stock. Trading at $0.98. Market cap: $272M. Capital Quality Rank: 68/100 — Above average.

Stock snapshot

Price$0.98
Market cap$272M
SectorHealthcare
ExchangeNCM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)68 / 100 · Above average
Revenue CAGR (3y)-6.9%
Shareholder buyback yield-17.97%
Altman Z-score zoneDistress

About AKBA

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, and HIF-PH inhibitors in preclinical development.

Listed2014Employees194HQCambridge, MASectorHealthcareWebsiteakebia.com

Related non-dividend companies

Other non-dividend stocks investors research alongside AKBA. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is AKBA's current stock price?

AKBA (Akebia Therapeutics, Inc.) is currently trading at $0.98.

Does AKBA pay a dividend?

AKBA (Akebia Therapeutics, Inc.) does not currently pay a regular dividend.

What is AKBA's Capital Quality Rank?

AKBA has a Capital Quality Rank of 68/100 — Above average. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track AKBA in DiviDrip

Add AKBA to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-09-03. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow